HHS to allow sale of unapproved peptides under review
7h agonow
What the source said
“HHS to allow sale of unapproved peptides under review”
The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to the those championed by the Make America Healthy Again (MAHA) agenda. HHS stated in a notice that it would be practicing enforcement discretion...
Read at The HillReported by one source so far. It is confirmed when a second, independent source reports the same thing.